• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐相关颌骨骨坏死中的氧化应激

Oxidative stress in bisphosphonate-related osteonecrosis of the jaws.

作者信息

Bagan Jose, Sáez Guillermo T, Tormos M Carmen, Gavalda-Esteve Carmen, Bagan Leticia, Leopoldo-Rodado Manuel, Calvo Javier, Camps Carlos

机构信息

Department of Oral Medicine, Valencia University, Valencia, Spain; Service of Stomatology and Maxillofacial Surgery, University General Hospital, Valencia, Spain.

出版信息

J Oral Pathol Med. 2014 May;43(5):371-7. doi: 10.1111/jop.12151. Epub 2014 Jan 23.

DOI:10.1111/jop.12151
PMID:24450511
Abstract

OBJECTIVES

To analyze whether oxidative stress (OS) changes are present in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ) versus controls.

MATERIALS AND METHODS

Oxidative stress was analyzed in serum and unstimulated saliva of three groups: Group 1 consisted of 24 patients who had been treated with intravenous bisphosphonates (ivBPs) and developed BRONJ, group 2 consisted of 20 patients who had received ivBPs and did not develop BRONJ, and group 3 comprised 17 control subjects. Reduced glutathione (GSH), malondialdehyde (MDA), oxidized glutathione (GSSG), and 8-oxo-7,8-dihydro-2-deoxyguanosine (8-oxo-dG) levels, as well as the GSSG/GSH ratio, were measured.

RESULTS

Mean serum and saliva levels of MDA, GSSG, and 8-oxo-dG and the GSSG/GSH ratio were significantly higher in patients with BRONJ than in controls. We found no significant difference in OS according to BRONJ stage, sex, or location in the jaws. Logistic regression analysis revealed that the GSSG/GSH ratio was a significant factor predicting the development of BRONJ (P = 0.01).

CONCLUSIONS

Oxidative stress was detected in patients with BRONJ, and the GSSG/GSH ratio was the most significant OS variable found; it was a significant factor predicting the development of BRONJ.

摘要

目的

分析双膦酸盐相关颌骨坏死(BRONJ)患者与对照组相比是否存在氧化应激(OS)变化。

材料与方法

对三组患者的血清和未刺激唾液中的氧化应激进行分析:第一组由24例接受静脉注射双膦酸盐(ivBPs)并发生BRONJ的患者组成,第二组由20例接受ivBPs但未发生BRONJ的患者组成,第三组由17名对照受试者组成。测量还原型谷胱甘肽(GSH)、丙二醛(MDA)、氧化型谷胱甘肽(GSSG)和8-氧代-7,8-二氢-2'-脱氧鸟苷(8-氧代-dG)水平以及GSSG/GSH比值。

结果

BRONJ患者的血清和唾液中MDA、GSSG和8-氧代-dG的平均水平以及GSSG/GSH比值显著高于对照组。根据BRONJ分期、性别或颌骨位置,我们发现OS无显著差异。逻辑回归分析显示,GSSG/GSH比值是预测BRONJ发生的重要因素(P = 0.01)。

结论

在BRONJ患者中检测到氧化应激,GSSG/GSH比值是发现的最显著的OS变量;它是预测BRONJ发生的重要因素。

相似文献

1
Oxidative stress in bisphosphonate-related osteonecrosis of the jaws.双膦酸盐相关颌骨骨坏死中的氧化应激
J Oral Pathol Med. 2014 May;43(5):371-7. doi: 10.1111/jop.12151. Epub 2014 Jan 23.
2
Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws.双膦酸盐相关颌骨骨坏死患者血浆和唾液中白细胞介素-6浓度的变化
Oral Dis. 2014 Jul;20(5):446-52. doi: 10.1111/odi.12150. Epub 2013 Jul 10.
3
Oxidative stress markers in pre-uremic patients.尿毒症前期患者的氧化应激标志物。
Clin Nephrol. 2001 Oct;56(4):308-14.
4
Bisphosphonate related osteonecrosis of the jaws: clinico-pathological investigation and histomorphometric analysis.双膦酸盐相关性颌骨坏死:临床病理研究与组织形态计量分析。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May;115(5):660-6. doi: 10.1016/j.oooo.2013.03.001.
5
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.长期静脉注射双膦酸盐治疗停药后双膦酸盐相关颌骨坏死患者的骨转换和血管生成血清标志物
J Oral Maxillofac Surg. 2016 Apr;74(4):738-46. doi: 10.1016/j.joms.2015.09.028. Epub 2015 Oct 3.
6
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.用于预测接受双膦酸盐治疗患者颌骨坏死发生情况的血清学骨标志物。
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
7
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension.尿8-氧代-7,8-二氢-2'-脱氧鸟苷(8-氧代-dG),高血压中一种可靠的氧化应激标志物。
Free Radic Res. 2007 May;41(5):546-54. doi: 10.1080/10715760601164050.
8
Insulin resistance and oxidative stress in familial combined hyperlipidemia.家族性混合性高脂血症中的胰岛素抵抗与氧化应激
Atherosclerosis. 2008 Aug;199(2):384-9. doi: 10.1016/j.atherosclerosis.2007.11.023. Epub 2007 Dec 31.
9
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
10
Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.乳腺癌患者静脉注射双膦酸盐相关颌骨骨坏死早期阶段的特征
Acta Odontol Scand. 2014 Nov;72(8):656-63. doi: 10.3109/00016357.2014.887772. Epub 2014 Feb 12.

引用本文的文献

1
Fatty Degenerative Osteonecrosis of the Jaw: Bridging Molecular Insights and Clinical Practice-A Scoping Review.颌骨脂肪性变性骨坏死:连接分子见解与临床实践——一项范围综述
Int J Mol Sci. 2025 Feb 21;26(5):1853. doi: 10.3390/ijms26051853.
2
A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials.激光光生物调节剂量学与治疗方案在药物相关性颌骨坏死管理中的系统评价:对未来随机对照临床试验的合理共识
Pharmaceuticals (Basel). 2024 Jul 31;17(8):1011. doi: 10.3390/ph17081011.
3
Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.
当使用唑来膦酸的肿瘤剂量治疗时,炎症可以通过调节 SIRT1 信号成为 MRONJ 黏膜不愈合的高危因素。
Drug Des Devel Ther. 2024 Jul 4;18:2793-2812. doi: 10.2147/DDDT.S456811. eCollection 2024.
4
S-Allylmercapto-N-Acetylcysteine (ASSNAC) Attenuates Osteoporosis in Ovariectomized (OVX) Mice.S-烯丙基巯基-N-乙酰半胱氨酸(ASSNAC)减轻去卵巢(OVX)小鼠的骨质疏松症。
Antioxidants (Basel). 2024 Apr 17;13(4):474. doi: 10.3390/antiox13040474.
5
Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis.臭氧疗法在药物相关性颌骨坏死预防或治疗中的作用:显微断层扫描、共聚焦激光显微镜及组织形态计量学分析
Clin Oral Investig. 2024 Feb 16;28(2):151. doi: 10.1007/s00784-024-05547-z.
6
ANOM Approach for Statistical Evaluation of Some Antioxidant Enzyme Activities.用于某些抗氧化酶活性统计评估的ANOM方法
Front Chem. 2022 May 26;10:894547. doi: 10.3389/fchem.2022.894547. eCollection 2022.
7
Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma.调节细胞氧化还原参数以改善多发性骨髓瘤的治疗反应
Antioxidants (Basel). 2022 Feb 25;11(3):455. doi: 10.3390/antiox11030455.
8
Zoledronic acid promotes osteoclasts ferroptosis by inhibiting FBXO9-mediated p53 ubiquitination and degradation.唑来膦酸通过抑制FBXO9介导的p53泛素化和降解促进破骨细胞铁死亡。
PeerJ. 2021 Dec 16;9:e12510. doi: 10.7717/peerj.12510. eCollection 2021.
9
Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.治疗药物相关性颌骨坏死(MRONJ)的各种治疗方法及其局限性:关于新的分子和细胞治疗方法的叙述性综述
Antioxidants (Basel). 2021 Apr 27;10(5):680. doi: 10.3390/antiox10050680.
10
Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?用于研究和临床实践中体外测量炎症和氧化应激的常见及新型标志物——就疾病结局而言应使用哪种标志物?
Antioxidants (Basel). 2021 Mar 9;10(3):414. doi: 10.3390/antiox10030414.